A synthetic peptide from the third hypervariable region of major histocompatibility complex class II beta chain as a vaccine for treatment of experimental autoimmune encephalomyelitis.

Ítems similars

• Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
  per: Sharma, S D, et al.
  Publicat: (1991)
• CDR1 T-cell receptor beta-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions.
  per: Broeren, C P, et al.
  Publicat: (1994)
• Isolation of chicken major histocompatibility complex class II (B-L) beta chain sequences: comparison with mammalian beta chains and expression in lymphoid organs.
  per: Bourlet, Y, et al.
  Publicat: (1988)
• Unusual association of beta 2-microglobulin with certain class I heavy chains of the murine major histocompatibility complex.
  per: Bushkin, Y, et al.
  Publicat: (1986)
• Specific binding of antigenic peptides to separate alpha and beta chains of class II molecules of the major histocompatibility complex.
  per: Rothenhäusler, B, et al.
  Publicat: (1990)